Oscar Health, Inc. (OSCR)
Healthcare • Healthcare Plans
StockNYSEUnited StatesUS6877931096
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Oscar Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:05. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Feb 2027 08:00 | -1.12 | — | — | Upcoming |
| 05 Nov 2026 06:00 | -0.17 | 0.49 | +382.6% | Beat |
| 06 Aug 2026 06:00 | 0.38 | 1.10 | +189.2% | Beat |
| 06 May 2026 06:00 | 1.10 | 2.07 | +88.2% | Beat |
| 10 Feb 2026 06:00 | -0.92 | -1.24 | -34.6% | Miss |
| 06 Nov 2025 06:00 | -0.58 | -0.53 | +8.7% | Beat |
| 06 Aug 2025 06:00 | -0.84 | -0.89 | -6.5% | Miss |
| 07 May 2025 06:00 | 0.81 | 0.92 | +13.9% | Beat |
| 04 Feb 2025 16:00 | -0.58 | -0.62 | -6.5% | Miss |
| 07 Nov 2024 06:00 | -0.18 | -0.22 | -25.0% | Miss |
| 07 Aug 2024 06:00 | 0.16 | 0.20 | +29.0% | Beat |
| 07 May 2024 06:00 | 0.27 | 0.62 | +129.6% | Beat |
| 07 Feb 2024 16:00 | -0.70 | -0.66 | +6.4% | Beat |
| 07 Nov 2023 06:00 | -0.47 | -0.29 | +39.0% | Beat |
| 08 Aug 2023 16:00 | -0.16 | -0.07 | +55.6% | Beat |
| 09 May 2023 16:00 | -0.09 | -0.18 | -100.0% | Miss |
| 09 Feb 2023 16:00 | -1.19 | -1.05 | +11.6% | Beat |
| 08 Nov 2022 16:00 | -0.69 | -0.91 | -31.9% | Miss |
| 11 Aug 2022 16:00 | -0.35 | -0.53 | -49.3% | Miss |
| 10 May 2022 16:00 | -0.12 | -0.36 | -193.9% | Miss |
| 10 Feb 2022 16:00 | -0.73 | -0.95 | -30.1% | Miss |
| 10 Nov 2021 16:00 | -0.65 | -1.02 | -56.9% | Miss |
| 12 Aug 2021 16:00 | -0.47 | -0.35 | +25.1% | Beat |
| 13 May 2021 16:00 | -0.54 | -0.75 | -37.7% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 11.7B | +27.5% | -443.2M | -3.8% | -1.69 | -1,790.0% | 1.1B |
| 2024 | 9.2B | +56.5% | 25.4M | 0.3% | 0.10 | +108.2% | 950.3M |
| 2023 | 5.9B | +42.1% | -270.7M | -4.6% | -1.22 | +57.2% | -297.7M |
| 2022 | 4.1B | — | -606.3M | -14.7% | -2.85 | — | 351.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 31.12 | 34.20 | 30.60 | 30.75 | +0.34% | 19,549,700 | |
| 02 Nov 2026 – 06 Nov 2026 | 30.42 | 38.50 | 29.62 | 30.65 | +0.92% | 42,816,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 31.00 | 32.35 | 29.94 | 30.37 | -2.00% | 19,076,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 32.05 | 34.28 | 30.68 | 30.99 | -2.82% | 22,153,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 33.70 | 35.01 | 31.65 | 31.89 | -4.44% | 27,381,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 30.97 | 34.14 | 30.84 | 33.37 | +7.85% | 24,455,700 | |
| 28 Sep 2026 – 02 Oct 2026 | 29.51 | 31.17 | 28.99 | 30.94 | +4.53% | 21,088,700 | |
| 21 Sep 2026 – 25 Sep 2026 | 31.00 | 32.16 | 28.30 | 29.60 | -7.87% | 32,881,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 33.02 | 34.48 | 30.75 | 32.13 | -1.95% | 30,747,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 32.00 | 34.23 | 30.44 | 32.77 | +1.61% | 21,174,500 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Best Growth Stocks to Buy for November 12th (opens in a new tab) Zacks · 12 Nov 2026 08:22
- HealthEx Partners with Oscar Insurance to Bring Members’ Medical Records Into the Oscar App (opens in a new tab) 10 Nov 2026 14:00
- Oscar Launches New Wave of Consumer Health Insurance Products to South Carolina Individuals and Families (opens in a new tab) 10 Nov 2026 12:03
- Oscar Grows Across Ohio to Serve Nearly the Entire State for 2027 Open Enrollment (opens in a new tab) 10 Nov 2026 12:01
- Best Growth Stocks to Buy for November 10th (opens in a new tab) Zacks · 10 Nov 2026 06:56
- OSCR Q3 2026 deep dive: management credits pricing discipline and technology for margin gains (opens in a new tab) StockStory · 09 Nov 2026 12:45
- What Oscar Health (OSCR) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 07 Nov 2026 21:14
- Oscar Health Inc (OSCR) Q3 2026 Earnings Call Highlights: Record Profitability, Raised Guidance ... (opens in a new tab) GuruFocus.com · 07 Nov 2026 08:08
- What Oscar Health Holders Bought Into Before A 122% Run (opens in a new tab) Simply Wall St. · 06 Nov 2026 18:16
- Oscar Health Seen on Positive Path After Better-Than-Expected Q3, UBS Says (opens in a new tab) MT Newswires · 06 Nov 2026 18:01
- Oscar Health (OSCR) Could Be 94% Undervalued Following Its Profit And Outlook Lift (opens in a new tab) Simply Wall St. · 06 Nov 2026 17:17
- Oscar Health Stock Earnings Beat Spurs Higher Full Year Outlook (opens in a new tab) Simply Wall St. · 06 Nov 2026 14:10
- Oscar Health, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Nov 2026 13:30
- OSCR Q3 Earnings Call Highlights Strong Outlook and Margin Gains (opens in a new tab) Zacks · 06 Nov 2026 12:24
- Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45 (opens in a new tab) Benzinga · 06 Nov 2026 10:24
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 31.94 USD
- Market cap
- 9.9B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.5 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 13.3 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 15.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 50: three or more warnings
- Thin interest cover: operating profit is only -23.8× the interest
- The last full year was a loss
- Total debt has risen three years in a row
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 14.27× | Good | 30.56× |
| P/E (forward) | 13.6× | Good | 14.16× |
| Price / book | 4.48× | Weak | 3.5× |
| Price / sales | 0.57× | Good | 3.33× |
| EV / EBITDA | 3.07× | Good | 11.19× |
| Free cash flow yield | 17.4% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 20.6% | Fair | 54.9% |
| Operating margin | 5.4% | Weak | 5.8% |
| Net margin | 4.9% | Weak | 1.2% |
| Return on equity | 52.6% | Good | 4.4% |
| Return on assets | 7.4% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 41.6% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.22× | Good | 0.4× |
| Net debt / EBITDA | -7.27× | Good | 1.46× |
| Interest cover | -23.85× | Weak | 2.17× |
| Current ratio | 1.14× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow OSCR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.